Gara Jalqabaatti › Kansa Glandii Saliva
Qorannoo klinikaalii Kansa Glandii Saliva Ameerikaa Keessatti hirmaatuu
Qorannoo 15 Kansa Glandii Saliva f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- Boston, MAQorannoo 5
- Nashville, TNQorannoo 5
- Houston, TXQorannoo 5
- New York City, NYQorannoo 4
- Philadelphia, PAQorannoo 3
- Dallas, TXQorannoo 3
- Highlands Ranch, COQorannoo 3
Naannoon
- CaliforniaQorannoo 4
- ColoradoQorannoo 5
- FloridaQorannoo 4
- IllinoisQorannoo 4
- KansasQorannoo 3
- MassachusettsQorannoo 6
- MinnesotaQorannoo 3
- New JerseyQorannoo 3
- New MexicoQorannoo 3
- New YorkQorannoo 5
- OhioQorannoo 4
- PennsylvaniaQorannoo 4
- TennesseeQorannoo 5
- TexasQorannoo 6
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
DESTINY-PANTUMOUR04
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 130 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07124000Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT05408845Phase II Trial of Sacituzumab Govitecan in Recurrent and/or Metastatic Secretory Gland Cancers
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ado-2026 · NCT05884320A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Ado-2026 · NCT06695845Integrated Cancer Repository for Cancer Research
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 19 hanga 110 · Saalaa hunda · Haaromfame 29-Wax-2026 · NCT02012699Oropharynx (OPX) Biomarker Trial
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Elb-2026 · NCT06356272Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Elb-2026 · NCT04620187Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Gur-2026 · NCT03740256Drug Screening Using Novel IMD in Salivary and Head and Neck Cancers
Namoota walitti qabaa jiraSadarkaa jalqabaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 26-Ama-2026 · NCT05553782VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 11-Mud-2025 · NCT03556228Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT00898638A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2025 · NCT05941507Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 21 hanga 90 · Saalaa hunda · Haaromfame 22-Ful-2025 · NCT00900419Physiologic MR Imaging of Salivary Gland Tumors
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2025 · NCT04452162A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Ado-2025 · NCT06805617Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.